2003
DOI: 10.1159/000069761
|View full text |Cite
|
Sign up to set email alerts
|

Parathyroid Hormone Has a Prosclerotic Effect on Vascular Smooth Muscle Cells

Abstract: Although accelerated atherosclerosis and arteriosclerosis are common in patients with renal failure, the pathogenesis of these changes is poorly understood. Parathyroid hormone (PTH) levels are elevated in renal failure, and have been linked to uraemic vascular changes in some studies. We examined the in vitro effects of increasing doses of the 1–34 fragment of PTH on human aortic vascular smooth muscle cells (VSMCs). Factors examined were: (1) collagen production using tritiated hydroxyproline incorporation a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
52
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(56 citation statements)
references
References 40 publications
2
52
0
1
Order By: Relevance
“…15,16 We did not assess these factors directly, although we found an inverse relationship between 25(OH)D levels and CRP.…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…15,16 We did not assess these factors directly, although we found an inverse relationship between 25(OH)D levels and CRP.…”
Section: Discussionmentioning
confidence: 87%
“…11 Low levels of vitamin D may alter the renin-angiotensin axis by direct suppression of renin gene expression 12 ; affect vascular endothelium through smooth muscle proliferation, 13 infl ammation, 12 and thrombosis 14 ; alter calcium channel fl uxes; and induce secondary hyperparathyrodism. Elevated parathyroid hormone has been linked to mortality in the elderly, 15 possibly through vascular effects, 16 although fi ndings regarding an association with cardiovascular mortality have been mixed. 17,18 These fi ndings suggest pathways through which low levels of vitamin D may increase the risk of cardiovascular-related morbidity (including hyperten-V I TA MIN D, R AC E, A ND C A R DIOVA S CUL A R M OR TA L I T Y sion, diabetes, renal, heart and cerebrovascular disease) and subsequent cardiovascular mortality.…”
mentioning
confidence: 99%
“…First, PTH has been implicated in vascular calcification in the setting of end-stage renal disease 47) , and it is a well-recognized contributor to arterial stiffening 48) . Second, PTH appears to also increase total collagen synthesis and reorganized collagen in cultured vascular smooth muscle cells 49) , although PTH also prevented bovine vascular smooth muscle cell calcification in vitro 50) . Third, higher PTH levels are associated with established covariates of arterial stifness, such as hypertension, obesity and and renal dysfunction 51) ; however, the fact that PTH remained significantly associated with aortic stiffness in all multivariable models suggests that confounding by these factors is not the sole explanation for our findings.…”
Section: Resultsmentioning
confidence: 99%
“…5 Genetic knockout models suggest vascular effects of vitamin D, including vascular endothelium, the renin-angiotensin axis, 6 and vascular smooth muscle including cell proliferation, 7 inflammation, 6 thrombosis, 8 cardiac hypertrophy, 9 and hyperparathyroid hormone secretion. 10 Prospective cohort data suggest low serum vitamin D levels might contribute to cardiovascular disease, 11 in part through elevated BP. 12 Serum vitamin D levels are largely driven by ultraviolet (UV) synthesis in the skin.…”
Section: Introductionmentioning
confidence: 99%